뒤로
Swedish Orphan Biovitrum AB (publ)(BIOVF) 가격
BIOVF 주가 차트
BIOVF 수입
Swedish Orphan Biovitrum AB (publ)
$37
0%
$0
종가: Jan 27, 16:00:00 GMT-5
$37
0%
$0
애프터마켓: Jan 27, 20:00:00 GMT-5
최신 수익 결과: Q3 '25
보고됨: 2025-10-20
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
BIOVF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Swedish Orphan Biovitrum AB (publ) BIOVF의 지난 분기 매출 실적은 어땠나요?
Swedish Orphan Biovitrum AB (publ)의 매출 추정치는 얼마인가요?
Swedish Orphan Biovitrum AB (publ)의 수익 품질 점수는 얼마인가요?
Swedish Orphan Biovitrum AB (publ)는 언제 수익을 보고하나요?
Swedish Orphan Biovitrum AB (publ)의 예상 수익은 얼마인가요?
Swedish Orphan Biovitrum AB (publ)은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$37
시가
$32.06
일일 범위
$32.06 - $37
52주 범위
$25.79 - $37
거래량
1
평균 거래량
32
EPS(TTM)
0.00
배당수익률
--
시가총액
$12.7B
SWEDISH ORPHAN BIOVITRUM AB란 무엇인가요?
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Stockholm, Stockholm and currently employs 1,890 full-time employees. The company went IPO on 2006-09-15. The firm develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The firm has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others.